EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation

Xinhui Zheng iD, Haixiao Zhang, Wenwen Guo, YiGeng Cao, Xin Liu, WeiHua Zhai, Xiaoyu Zhang, Fengjiao Wang, JiaLin Wei, DongLin Yang, Yong Huang, AiMing Pang iD und 3 weitere

European Journal of Haematology · 2023

DOI: 10.1111/ejh.13925 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, 2023. Verfasst von Xinhui Zheng und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Graft vs Host Disease. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Nature Science Foundation of China, Key Project of Tianjin Natural Science Foundation, CAMS Innovation Fund for Medical Sciences (CIFMS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The delayed platelet engraftment associated with allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is a common complication and often results in increased transplant‐related complications. A single‐center, prospective, investigator‐initiated pilot study was conducted to explore whether herombopag, a second generation thrombopoietin‐receptor agonist, would promote platelet engraftment after allo‐HSCT. Between 2/2022 and 06/2022, 17 individuals (median age 39; range 15–58 years) with hematological malignancies were enrolled. Herombopag was given for a median of 22 (range 14–61) days at a dose of 7.5 mg/d. The median time to neutrophil >500/μl was 11 (range 9–19) days. The median time to platelet >20 000/μl and >50 000/μl was 13 (range 8–22), and 20 (range 14–45) days, respectively. Compared with historical controls, the cumulative incidence of platelet engraftment after HSCT was significantly higher in the herombopag group (>20 000/μl at day +21, 88% vs 65%, p = .003; >50 000/μl at day +30, 65% vs. 43%, p = .001). Herombopag also reduced the units of platelet transfusion within 30 days post‐SCT (3.6 ± 2.5 vs. 5.4 ± 3.2 U, p = .01). In conclusion, it seems likely that herombopag could enhance platelet engraftment after allo‐HSCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationGraft vs Host DiseaseHumansAdultPlatelet TransfusionProspective StudiesPilot ProjectsBlood PlateletsRetrospective Studies

Stichwörter der Autor:innen

delayed platelet engraftmentengraftmenthematopoietic stem cell transplantationherombopagthrombopoietin-receptor agonist

Autor:innen und Institutionen

  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…

ORCID-Profile: Xinhui Zheng, AiMing Pang, ErLie Jiang

Förderung

  • National Nature Science Foundation of China
  • Key Project of Tianjin Natural Science Foundation
  • CAMS Innovation Fund for Medical Sciences (CIFMS)
  • Fundamental Research Funds for the Central Universities
  • Tianjin Natural Science Foundation
  • Haihe Laboratory of Cell Ecosystem Innovation Fund
  • Clinical research project of Tianjin Society of Hematology and Regenerative Medicine
  • National Natural Science Foundation of China

Zitieren

APA

Zheng, X., Zhang, H., Guo, W., Cao, Y., Liu, X., Zhai, W., Zhang, X., Wang, F., Wei, J., Yang, D., Huang, Y., Pang, A., Feng, S., Jiang, E., & Han, M. (2023). Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation. European Journal of Haematology. https://doi.org/10.1111/ejh.13925

Vancouver

Zheng X, Zhang H, Guo W, Cao Y, Liu X, Zhai W, et al. Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation. European Journal of Haematology. 2023. doi:10.1111/ejh.13925

BibTeX
@article{Zheng2023,
  author = {Zheng, Xinhui and Zhang, Haixiao and Guo, Wenwen and Cao, YiGeng and Liu, Xin and Zhai, WeiHua and Zhang, Xiaoyu and Wang, Fengjiao and Wei, JiaLin and Yang, DongLin and Huang, Yong and Pang, AiMing and Feng, SiZhou and Jiang, ErLie and Han, MingZhe},
  title = {Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation},
  journal = {European Journal of Haematology},
  year = {2023},
  doi = {10.1111/ejh.13925}
}
Kostenlos starten →